ScheBo® Company News

Pancreas Elastase 1 Quick Test study published in “Journal of Cystic Fibrosis” June-2016
Polish scientists publish a study of the sensitivity and specificity of the Pancreas Elastase 1 Quick test in comparison to the ELISA test in the “Journal of Cystic Fibrosis”.
Walkowiak et al.:
Pancreatic Elastase-1 Quick Test for rapid assessment of pancreatic status in cystic fibrosis patients
» link to the abstract

ISO-Certification
Succesful ISO Re-Certification of ScheBo® Biotech AG on August 8, 2015.
icon_pdf  Certificate EN ISO 13485
icon_pdf  Certificate EN ISO 9001

Malaysian Study: Newest data on the M2-PK test published in journal „PLOS ONE“ July-2015
Suresh Sithambaram, Ida Hilmi, Khean-Lee Goh:
The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test- A Rapid Office Based Assay Test for the Detection of Colorectal Cancer
» read more

Multicenter Study: Newest data on the M2-PK test published in journal „Gut and Liver“ January-2015
Kim YC, et al.:
The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test
» read more

ScheBo® Pancreas Elastase 1 Quick™ Canine test
Stool test for the fast and reliable diagnosis/ exclusion of Exocrine Pancreatic Insufficiency
… now also available as a rapid test
The new ScheBo® Pancreas Elastase 1 Quick™ Canine is a rapid test to quickly and conveniently exclude or diagnose canine EPI in your own surgery.
» link to the product

ScheBo® Pancreas Elastase 1 Quick™ test
Faecal Pancreatic Elastase 1
The Gold Standard for Non-Invasive Exocrine Pancreatic Function Testing
… now also available as a rapid test
The ScheBo® Pancreas Elastase 1 Quick™ stool test is a reliable and easy to perform rapid test for the detection of Pancreatic Elastase 1 in stool samples.
» link to the product

Gastroenterology 2013, 144: 602
icon_pdf Sung, Joseph J. S. et al.:
The use of a new stool test M2-PK in the diganosis of colorectal cancer: A case-control study

Journal of Gastroenterology and Hepatology 2013, 28
icon_pdf Suresh Sithambaram Suresh et al.:
Colonic and Anorectal Disorders M2PK – A new immunochromotographic testing for colorectal carcinoma screening: Preliminary results

2in1 Colorectal Cancer Screening Test
New innovative combined rapid test to simultaneously detect the enzyme biomarker M2-PK and human haemoglobin for improved colorectal cancer screening.
The ScheBo® 2in1 Quick™ test is a brand new colorectal cancer-screening test, which can detect colorectal cancers and polyps by simultaneously using direct (M2-PK) and indirect methods (iFOBT). An innovation, the ScheBo® 2in1 Quick™ test is able to detect both non-bleeding and bleeding colorectal cancers and polyps.
» link to the product

World Journal of Gastroenterology, 2012 August 14; 18 (30):4004 – 4011
Tonus, Carolin; Sellinger, Markus; Koss, Konrad; Neupert, Gero:
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening:
A meta-analysis
» link to the publication

AEO-Certificate
icon_pdfThe Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.

ACB News, Issue 570, October 2010
icon_pdf Corporate News: ScheBo Biotech and M2-PK

Science 17 September 2010, Vol. 329. no. 5998, pp. 1492 – 1499
Matthew G. Vander Heiden et. al.:
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
» link to the abstract

Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in the Current Issue of ′Science′:
Cancer research is facing a radical change of direction. Cancer cells do not obtain their energy from the breakdown of sugar to carbon dioxide and water, but from energy-rich intermediates of sugar metabolism instead.
» link to the article

Video from the Focus 2009 meeting
Dr. David Sanders: Stool Tests Help Gastroenterologists
Focusing on results with faecal pancreatic elastase and faecal lactoferrin from clinical studies conducted at the Royal Hallamshire Hospital in Sheffield, Dr David Sanders discusses the clinical value of faecal diagnostic assays
» link to the video

Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:
Pyruvate kinase M2 is a phosphotyrosine-binding protein
» link to the abstract

Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
» link to the abstract

Castle Rauischholzhausen March 7-8, 2008
icon_pdfSecond Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases

Veterinary Microbiology, Volume 123, Issue 4, 31-Aug-2007, S. 336-345
Schönenbrücher, H. et al.:
Detection of central nervous system tissues in meat products: Validation and standardization of a real-time PCR-based detection system
» link to the abstract

Pharmaceutical International
Leeds, John S.; Sanders, David S.:
Coeliac disease and pancreatic exocrine insufficiency
» link to the article

Alimentary Pharmacology & Therapeutics, February 2007, Volume 25, Issue 3, S. 265-271
Leeds, John S. et al.:
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
» link to the article

British Journal of Cancer, 2007, Volume 96, S. 1329-1334
Haug, U. et al.:
Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients
» link to the article

European Journal of Gastroenterology & Hepatology, March 2007, 9(3), S.265-276
Kumar, Y. et al.:
Tumour M2-pyruvate kinase: a gastrointestinal cancer marker
» link to the article

World Journal of Gastroenterology 2006 November 21; 12 (43)
Tonus, C.; Neupert, G.; Sellinger, M.:
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
» link to the article

38th Meeting of the European Pancreatic Club (EPC), Tampere, Finland, June 7-10, 2006
icon_pdf Ewald, N. et al.:
Prevalence of diabetis melitus secondary to pancreatic diseases (type 3c)

13th UEGW (United European Gastroenterology Week), Copenhagen, Denmark, October 15-19, 2005
icon_pdfEwald, N. et al.:
Pyruvate kinase M2 (Tumor M2-PK) as a screening tool for colorectal cancer (CRC)

NCRI Conference, Birmingham, UK, 2.-5. Oktober 2005
icon_pdfMcLoughlin, R.M. et al.:
Tumour M2-PK, a novel screening tool for colorectal cancer

ASCO 41st Annual Meeting, Orlando, Florida, USA, 13.-17. Mai 2005
icon_pdfKlör, H.U. et al.:
The tumor metabolic marker Tumor M2-PK in stool: a new biomarker for colorectal cancer

Vet Clin Pathol. 2005; 34(1): 49-51
icon_pdf Battersby IA, Peters IR, Day MJ, German AJ, Hall EJ.:
Effect of intestinal inflammation on fecal elastase concentration in dogs

Pharmaceutical International
Smith, Ivor:
Faster and Easier ScheBo® • Biotech ′Feacal Elastase Test′
» link to the article

Clinical Advances in Hematology and Oncology, October 2004
icon_pdf Clinical Symposia Report: Advances in Gastrointestinal Cancer: A Report from the World GI Congress, June 16-19, 2004, Barcelona, Spain

cancerconsultants.com, Cancer News Article, 6. Oktober 2004
icon_pdf New Fecal Screening Test Shows Promise in Detecting Colorectal Cancer

British Journal of Cancer, Press Release, 25. August 2004
icon_pdf Enzyme signpost points to better colon cancer test

BBC News, 24. August 2004
icon_pdf ′Better′ bowel cancer test found

washingtontimes.com, 24. August 2004
icon_pdf Germans develop new colon cancer test

Cancer Compass, 30. Juli 2004
icon_pdf Scientists Present A New Colorectal Cancer Test, Tumour M2-PK

Abstract from the World Congress on Gastrointestinal Cancer, June 16-19, 2004, Barcelona, Spain
icon_pdf Hardt, P.D., et al:
Tumor M2-PK in Stool: A Screening Tool for Colorectal Cancer